site stats

Cisplatin full prescribing information

WebFeb 16, 2024 · What is cisplatin? Cisplatin is used together with other cancer drugs to treat bladder cancer, testicular cancer, or ovarian cancer. Cisplatin may also be used for purposes not listed in this medication guide. Warnings Cisplatin can affect your nervous system, increase your risk of bleeding or infection, or harm your kidneys. WebSee Full Prescribing Information for clinically significant drug interactions. (7.1, 7.2) ----- USE IN SPECIFIC POPULATIONS ----- Pregnancy: Can cause fetal harm. Advise pregnant women of the potential See 17 for PATIENT COUNSELING INFORMATION and Medication Guide. Revised: 11/2024

Label and Warnings 16729-522 Pemetrexed - ndclist.com

WebFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Refractory Testicular Tumors ETOPOPHOS is indicated, in combination with other chemotherapeutic drugs, for treatment of patients with refractory testicular tumors. 1.2 Small Cell Lung Cancer ETOPOPHOS is indicated, in combination with cisplatin, for first-line treatment of … WebApr 11, 2024 · On 3 April 2024, the US Food and Drug Administration (FDA) granted accelerated approval to enfortumab vedotin-ejfv (Padcev, Astellas Pharma) with pembrolizumab (Keytruda, Merck) for patients with locally advanced or metastatic urothelial carcinoma who are ineligible for cisplatin-containing chemotherapy. Full prescribing … grammarly support chat https://amaaradesigns.com

FULL PRESCRIBING INFORMATION - Food and Drug …

WebJul 18, 2024 · Cisplatin Brand name: Platinol-AQ Drug class: Antineoplastic Agents - Platinum-containing Agents VA class: AN900 Chemical name: (SP-4-2) … WebCISPLATIN INJECTION safely and effectively. See full pres cribing information for CISPLATIN INJECTION . CISPLATIN for injection , for intravenous use . Init ial U.S. … Web• CYP3A4 Interactions: Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4; see Full Prescribing Information for recommendations regarding contraindications, risk of adverse reactions, and dosage adjustment of fosaprepitant and concomitant drugs. china selling weapons to afghanistan

HIGHLIGHTS OF PRESCRIBING INFORMATION …

Category:These highlights do not include all the information needed to use ...

Tags:Cisplatin full prescribing information

Cisplatin full prescribing information

Avastin® (bevacizumab) Efficacy, Safety, Dosing & Prescribing Information

Web17 PATIENT COUNSELING INFORMATION *Sections or subsections omitted from the full prescribing information are not listed. FULL PRESCRIBING INFORMATION WARNING: EMBRYO-FETAL TOXICITY AND VENOUS THROMBOEMBOLISM EMBRYO-FETAL TOXICITY If THALOMID (thalidomide) is taken during pregnancy, it can cause severe …

Cisplatin full prescribing information

Did you know?

WebSee full prescribing information for complete boxed warning. Do not initiate topotecan treatment in patients with bone marrow suppression (e.g., neutrophil counts less than 1,500 cells/mm. ... in combination therapy with cisplatin, for the treatment of stage IVB, recurrent, or persistent carcinoma of the cervix which is not amenable to ... WebFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Pemetrexed for Injection is indicated: • In combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC).

WebJun 8, 2024 · Cisplatin injection has been administered at 50 mg/m 2 to 70 mg/m 2 intravenously per cycle once every 3 to 4 weeks. For heavily pretreated patients, an initial dose of 50 mg/m 2 per cycle repeated … WebFULL PRESCRIBING INFORMATION WARNING: MYELOSUPPRESSION HYCAMTIN can cause severe myelosuppression. Administer first cycle only to patients withbaseline …

WebFeb 20, 2024 · Gemzar Prescribing Information Package insert / product label Generic name: gemcitabine hydrochloride Dosage form: injection, powder, lyophilized, for solution Drug class: Antimetabolites Medically reviewed by Drugs.com. Last updated on Feb 20, 2024. On This Page Indications and Usage Dosage and Administration Dosage Forms … WebFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Refractory Testicular Tumors ETOPOPHOS is indicated, in combination with other chemotherapeutic drugs, for treatment of patients with refractory testicular tumors. 1.2 Small Cell Lung Cancer ETOPOPHOS is indicated, in combination with cisplatin, for firstline- treatment of …

WebCARBOPLATIN (carboplatin) This product information is intended only for residents of the United States. for Consumers: CARBOPLATIN, Vial U.S. Patient information CARBOPLATIN Novaplus Vial, U.S. Patient Information for Healthcare professionals: CARBOPLATIN, Vial U.S. Physician Prescribing Information

WebSep 20, 2024 · Sodium thiosulfate is administered as an intravenous infusion over 15 minutes following cisplatin infusions that are 1 to 6 hours in duration. View full … china sell weapons to russiaWebEfficacy for patients ineligible for cisplatin-containing chemotherapy was evaluated in Cohort 2 of EV-201 (NCT03219333), a single-arm, multi-cohort, international trial in 89 … grammarly support.comWebFULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Nonsquamous Non-Small Cell Lung Cancer – Combination with Cisplatin 1.2 Nonsquamous Non-Small Cell Lung Cancer... grammarly support display settingsWebSee full prescribing information for complete boxed warning. ... • are ineligible for cisplatin -containing chemotherapy and have previously received one or more prior lines … china sells u.s. lng to europeWebVoriconazole (see complete prescribing information for VFEND): Repeat oral dose administration of voriconazole (400 mg every 12 hours for one day, then 200 mg every 12 hours for 6 days) increased tacrolimus (0.1 mg/kg single dose) C max and AUCτ in healthy subjects by an average of 2-fold (90% CI: 1.9, 2.5) and 3-fold (90% CI: 2.7, 3.8 ... china sells u.s. lngWebSee full prescribing information for complete boxed warning Cardiomyopathy: trastuzumab products can result in subclinical and clinical cardiac failure manifesting as CHF, and decreased LVEF, with greatest risk when administered ... Ontruzant is indicated, in combination with cisplatin and capecitabine or 5-fluorouracil, china semiconductor foundryWebcisplatin ove rdose due to confusion with carboplatin or prescribing practices that fail to differentiate daily doses from total dose per cycle. DESCRIPTION . Cisplatin Injection infusion concentrate is a clear, colorless, sterile aqueous solution available in amber vials. Each 50 mL or 100 mL amber vial of infusion concentrate contains: 1 mg/mL china semi electric hospital bed